Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 8 studies | 27% ± 18% | |
glutamatergic neuron | 8 studies | 42% ± 24% | |
oligodendrocyte precursor cell | 8 studies | 27% ± 12% | |
GABAergic neuron | 5 studies | 48% ± 16% | |
endothelial cell | 3 studies | 30% ± 14% | |
GABAergic interneuron | 3 studies | 25% ± 4% | |
retinal ganglion cell | 3 studies | 36% ± 28% | |
interneuron | 3 studies | 52% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 31% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 462.18 | 2583 / 2642 | 97% | 13.34 | 687 / 705 |
prostate | 96% | 431.23 | 234 / 245 | 99% | 23.30 | 497 / 502 |
adrenal gland | 100% | 2745.11 | 258 / 258 | 74% | 5.22 | 170 / 230 |
lung | 87% | 222.84 | 505 / 578 | 20% | 0.36 | 231 / 1155 |
pancreas | 100% | 239.72 | 327 / 328 | 6% | 0.13 | 10 / 178 |
liver | 92% | 499.43 | 209 / 226 | 13% | 0.46 | 52 / 406 |
bladder | 90% | 242.14 | 19 / 21 | 10% | 0.23 | 49 / 504 |
heart | 92% | 328.64 | 792 / 861 | 0% | 0 | 0 / 0 |
uterus | 76% | 213.31 | 129 / 170 | 11% | 0.57 | 50 / 459 |
skin | 12% | 8.64 | 210 / 1809 | 61% | 5.37 | 290 / 472 |
esophagus | 52% | 109.62 | 750 / 1445 | 4% | 0.07 | 7 / 183 |
intestine | 44% | 65.78 | 422 / 966 | 10% | 0.19 | 53 / 527 |
muscle | 52% | 84.49 | 416 / 803 | 0% | 0 | 0 / 0 |
kidney | 35% | 37.30 | 31 / 89 | 12% | 0.18 | 105 / 901 |
stomach | 34% | 47.27 | 122 / 359 | 8% | 0.16 | 23 / 286 |
breast | 22% | 21.69 | 100 / 459 | 12% | 0.21 | 134 / 1118 |
eye | 0% | 0 | 0 / 0 | 34% | 0.85 | 27 / 80 |
ovary | 28% | 25.93 | 51 / 180 | 4% | 0.16 | 17 / 430 |
thymus | 24% | 19.50 | 156 / 653 | 5% | 0.08 | 29 / 605 |
adipose | 18% | 16.52 | 213 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.75 | 5 / 29 |
spleen | 8% | 6.29 | 20 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 7% | 8.37 | 90 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.13 | 3 / 45 |
peripheral blood | 3% | 4.55 | 25 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0098914 | Biological process | membrane repolarization during atrial cardiac muscle cell action potential |
GO_0006813 | Biological process | potassium ion transport |
GO_1901379 | Biological process | regulation of potassium ion transmembrane transport |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0009986 | Cellular component | cell surface |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0016020 | Cellular component | membrane |
GO_0030018 | Cellular component | Z disc |
GO_0016286 | Molecular function | small conductance calcium-activated potassium channel activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0015269 | Molecular function | calcium-activated potassium channel activity |
GO_0051393 | Molecular function | alpha-actinin binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0005515 | Molecular function | protein binding |
GO_0005242 | Molecular function | inward rectifier potassium channel activity |
Gene name | KCNN2 |
Protein name | Potassium calcium-activated channel subfamily N member 2 Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2) |
Synonyms | |
Description | FUNCTION: Forms a voltage-independent potassium channel activated by intracellular calcium . Activation is followed by membrane hyperpolarization. Thought to regulate neuronal excitability by contributing to the slow component of synaptic afterhyperpolarization. . |
Accessions | ENST00000507750.5 ENST00000505491.1 A0A0J9YW81 Q9H2S1 A0A9L9PY74 ENST00000512097.10 D6RGY7 A0A3F2YNY5 ENST00000631899.2 A0A669KBH3 ENST00000503706.5 [Q9H2S1-2] ENST00000673685.1 |